Viemed Healthcare Inc. (VMD)
Viemed Healthcare Statistics
Share Statistics
Viemed Healthcare has 39.52M shares outstanding. The number of shares has increased by 1.81% in one year.
| Shares Outstanding | 39.52M |
| Shares Change (YoY) | 1.81% |
| Shares Change (QoQ) | 1.5% |
| Owned by Institutions (%) | 64.56% |
| Shares Floating | 34.29M |
| Failed to Deliver (FTD) Shares | 2.02K |
| FTD / Avg. Volume | 1.78% |
Short Selling Information
The latest short interest is 339.95K, so 0.87% of the outstanding shares have been sold short.
| Short Interest | 339.95K |
| Short % of Shares Out | 0.87% |
| Short % of Float | 1% |
| Short Ratio (days to cover) | 2.73 |
Valuation Ratios
The PE ratio is 27.59 and the forward PE ratio is 11.59. Viemed Healthcare's PEG ratio is 3.72.
| PE Ratio | 27.59 |
| Forward PE | 11.59 |
| PS Ratio | 1.39 |
| Forward PS | 0.9 |
| PB Ratio | 2.37 |
| P/FCF Ratio | 235.82 |
| PEG Ratio | 3.72 |
Enterprise Valuation
Viemed Healthcare has an Enterprise Value (EV) of 300.14M.
| EV / Sales | 1.34 |
| EV / EBITDA | 17.94 |
| EV / EBIT | 7.68 |
| EV / FCF | 227.72 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.42 |
| Quick Ratio | 1.3 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 5.21 |
| Interest Coverage | 23.07 |
Financial Efficiency
Return on Equity is 8.57% and Return on Invested Capital is 8.96%.
| Return on Equity | 8.57% |
| Return on Assets | 6.36% |
| Return on Invested Capital | 8.96% |
| Revenue Per Employee | $190.21K |
| Profits Per Employee | $9.55K |
| Employee Count | 1,179 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 21.08 |
Taxes
| Income Tax | 4.76M |
| Effective Tax Rate | 29.44% |
Stock Price Statistics
The stock price has increased by -15.14% in the last 52 weeks. The beta is 1.64, so Viemed Healthcare's price volatility has been higher than the market average.
| Beta | 1.64 |
| 52-Week Price Change | -15.14% |
| 50-Day Moving Average | 7.27 |
| 200-Day Moving Average | 7.84 |
| Relative Strength Index (RSI) | 48.83 |
| Average Volume (20 Days) | 113.53K |
Income Statement
In the last 12 months, Viemed Healthcare had revenue of 224.26M and earned 11.27M in profits. Earnings per share was 0.29.
| Revenue | 224.26M |
| Gross Profit | 133.2M |
| Operating Income | 17.9M |
| Net Income | 11.27M |
| EBITDA | 16.73M |
| EBIT | 15.39M |
| Earnings Per Share (EPS) | 0.29 |
Balance Sheet
The company has 17.54M in cash and 6.87M in debt, giving a net cash position of 10.67M.
| Cash & Cash Equivalents | 17.54M |
| Total Debt | 6.87M |
| Net Cash | 10.67M |
| Retained Earnings | 89.69M |
| Total Assets | 177.07M |
| Working Capital | 15.55M |
Cash Flow
In the last 12 months, operating cash flow was 39.09M and capital expenditures -37.77M, giving a free cash flow of 1.32M.
| Operating Cash Flow | 39.09M |
| Capital Expenditures | -37.77M |
| Free Cash Flow | 1.32M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 59.4%, with operating and profit margins of 7.98% and 5.02%.
| Gross Margin | 59.4% |
| Operating Margin | 7.98% |
| Pretax Margin | 7.21% |
| Profit Margin | 5.02% |
| EBITDA Margin | 7.46% |
| EBIT Margin | 7.98% |
| FCF Margin | 0.59% |
Dividends & Yields
VMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3.62% |
| FCF Yield | 0.42% |
Analyst Forecast
Currently there are no analyst rating for VMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 6.26 |
| Piotroski F-Score | 7 |